Infinity Discovery, Inc.
Records under this name other than patents Infinity Discovery, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Back to Infinity Discovery, Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,230,004 | Cyclopamine analogues and methods of use thereof Formerly held Term ended Term ended Oct 25, 2025 · From the USPTO record | Term ended | Term ended Oct 25, 2025 | From the USPTO record |
| US 7,407,967 | Cyclopamine analogues and methods of use thereof Formerly held Term ended Term ended Aug 26, 2025 · From the USPTO record | Term ended | Term ended Aug 26, 2025 | From the USPTO record |
| US 7,875,628 | Cyclopamine analogues and methods of use thereof Formerly held Term ended Ended no later than Aug 26, 2025 · From the USPTO record | Term ended | Ended no later than Aug 26, 2025 | From the USPTO record |
| US 8,329,675 | Inhibitors of fatty acid amide hydrolase Formerly held Lapsed on the fee record Ended Dec 11, 2024 · From the USPTO record | Lapsed on the fee record | Ended Dec 11, 2024 | From the USPTO record |
| US 7,947,663 | Inhibitors of fatty acid amide hydrolase Formerly held Lapsed on the fee record Ended May 24, 2023 · From the USPTO record | Lapsed on the fee record | Ended May 24, 2023 | From the USPTO record |
| US 8,629,125 | Inhibitors of fatty acid amide hydrolase Formerly held Lapsed on the fee record Ended Jan 14, 2022 · From the USPTO record | Lapsed on the fee record | Ended Jan 14, 2022 | From the USPTO record |
| US 8,431,566 | Cyclopamine lactam analogs and methods of use thereof Formerly held Lapsed on the fee record Ended Apr 30, 2021 · From the USPTO record | Lapsed on the fee record | Ended Apr 30, 2021 | From the USPTO record |
| US 8,426,436 | Heterocyclic cyclopamine analogs and methods of use thereof Formerly held Lapsed on the fee record Ended Apr 23, 2021 · From the USPTO record | Lapsed on the fee record | Ended Apr 23, 2021 | From the USPTO record |
| US 8,357,676 | Ansamycin formulations and methods of use thereof Lapsed on the fee record Ended Jan 22, 2021 · From the USPTO record | Lapsed on the fee record | Ended Jan 22, 2021 | From the USPTO record |
| US 8,293,760 | Cyclopamine lactam analogs and methods of use thereof Formerly held Lapsed on the fee record Ended Oct 23, 2020 · From the USPTO record | Lapsed on the fee record | Ended Oct 23, 2020 | From the USPTO record |